Health Care & Life Sciences » Pharmaceuticals | Jaguar Animal Health Inc.

Jaguar Animal Health Inc.

Jaguar Animal Health Inc.
Stock Exchange NASDAQ Stock Market
EPS
$119.31
Market Cap
$173.33 M
Shares Outstanding
1.37 M
Public Float
20.38 M

Profile

Address
201 Mission Street
San Francisco California 94105
United States
Employees -
Website http://www.jaguar.health
Updated 07/08/2019
Jaguar Health, Inc. engages in the dvelopment of gastrointestinal products for both human prescription use and animals. Its products include Mytesi, Canalevia, Equilevia, and Neonorm. The Mytesi product IS use for relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Financials

View All

David MacNaughtan
Director
Gregory J. Divis
Director